Dose-Ranging Efficacy and Safety Study of Albuterol Multidose Dry Powder Inhaler (MDPI) vs Albuterol Hydrofluoroalkane (HFA) and Placebo MDPI in Children With Asthma

被引：0

作者：

Qaqundah, Paul Y. ^{[1
]}

Taveras, Herminia ^{[2
]}

Iverson, Harald ^{[2
]}

Shore, Paul ^{[3
]}

Shah, Tushar P. ^{[3
]}

机构：

[1] Pediat Care Med Grp Inc, Huntington Beach, CA USA

[2] Teva Pharmaceut, Miami, FL USA

[3] Teva Pharmaceut, Frazer, PA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2016年 / 137卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2015.12.1277

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

686

引用

页码：AB211 / AB211

页数：1

共 36 条

[21] A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma
Nathan, RA
Li, JTC
Finn, A
Jones, R
Payne, JE
Wolford, JP
Harding, SM
CHEST, 2000, 118 (02) : 296 - 302
[22] Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies
Kerwin, Edward M.
Taveras, Herminia
Iverson, Harald
Wayne, Denise
Shah, Tushar
Lepore, Mark S.
Miller, David S.
CLINICAL DRUG INVESTIGATION, 2016, 36 (01) : 55 - 65
[23] Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies
Edward M. Kerwin
Herminia Taveras
Harald Iverson
Denise Wayne
Tushar Shah
Mark S. Lepore
David S. Miller
Clinical Drug Investigation, 2016, 36 : 55 - 65
[24] A NOVEL ALBUTEROL MULTIDOSE DRY POWDER INHALER IN ADULT AND ADOLESCENT PATIENTS WITH EXERCISE-INDUCED BRONCHOCONSTRICTION: A SINGLE-DOSE STUDY.
Ostrom, N.
Taveras, H.
Iverson, H.
Pearlman, D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A40 - A40
[25] A Double-Blind Placebo-Controlled, Multicenter, Cross-Over, Dose-Ranging Study to Compare the Efficacy and Safety of Albuterol Spiromax and Proair HFA in Adult and Adolescent Patients Ages 12 and Older with Persistent Asthma
Kerwin, Edward M.
Taveras, Herminia
Iverson, Harald
Wayne, Denise
Shah, Tushar
Lepore, Mark S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB5 - AB5
[26] Efficacy and tolerability of beclomethasone dipropionate delivered by a novel multidose dry powder inhaler (Clickhaler®) versus a metered-dose inhaler in children with asthma
Adler, LM
Anand, C
Wright, FGD
Barrett, CF
McKeith, D
Clark, WIC
Maksimczyk, P
Martin, GDR
McKinnon, C
Raffles, AKM
Buck, H
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (11): : 758 - 769
[27] A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
Bensch, G
Lapidus, RJ
Levine, BE
Lumry, W
Yegen, Ü
Kiselev, P
Della Cioppa, G
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (01) : 19 - 27
[28] Efficacy, tolerability, and effect on asthma-related quality of life of formoterol BID via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma:: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study
Busse, W
Levine, B
Andriano, K
Lavecchia, C
Yegen, Ü
CLINICAL THERAPEUTICS, 2004, 26 (10) : 1587 - 1598
[29] Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator
O'Connor, B
Bonnaud, G
Haahtela, T
Luna, JM
Querfurt, H
Wegener, T
Lutsky, BN
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (04) : 397 - 404
[30] Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study
Ostrom, Nancy K.
Taveras, Herminia
Iverson, Harald
Pearlman, David S.
RESPIRATORY MEDICINE, 2015, 109 (11) : 1410 - 1415

← 1 2 3 4 →